Proton Pump Inhibitors and Risk of Drug Interactions

Journal Title: Гастроентерологія - Year 2015, Vol 2, Issue 56

Abstract

In the article, the current data regarding drug interactions of proton pomp inhibitors (PPI) with other preparations are discussed. It is concluded that the risk of adverse drug interactions is enhanced by the use of PPIs and drugs primarily metabolized by cytochrome isoenzyme CYP2C19. If the simultaneous application of IPP with many other drugs, including clopidogrel, is necessary, the preference should be given to pantoprazole.

Authors and Affiliations

S. M. Tkach, L. A. Onishchuk

Keywords

Related Articles

Enzyme Therapy of Chronic Pancreatitis with Exocrine Pancreatic Insufficiency

The article deals with diagnosis and treatment of chronic pancreatitis. The special attention was paid to the problem of exocrine pancreatic insufficiency. The principles of rational enzyme therapy were shown. There were...

Age-related and gender features of circulating immune complexes and lipid metabolism in inflammatory bowel diseases

Background. The purpose of the present work was to assess the level of circulating immune comple­xes (CIC) and lipid metabolism state in patients with inflammatory bowel disease (IBD). Materials and methods. We examined...

Quantitative analysis of the rate of the antisecretory effect of combined proton pump inhibitor Ezolong

Background. The treatment of acid-related diseases is an urgent problem of modern gastroenterology and is due to the wide spread of this group of nosologies in the structure of gastrointestinal pathology. Proton pump inh...

Digestive system diseases: the actual problem of clinical medicine

Background. Worldwide, the number of people suffe­ring from gastrointestinal and hepatobiliary diseases is increasing annually, and, therefore, they need specialized gastroenterological assistance. The objective is to id...

The Role of Buccal Epithelial Cells Properties to Adhesion of Candida albicans and Influence on It of Regulatory Cytokines During Infectious Process in Patients with Candidiasis of the Mucosa of the Upper Digestive Tract

The role of buccal epithelial cells in candidiasis development and the interrelation with peculiarities of cytokine balance in patients with candidiasis of the upper digestive tract continues to be studied today. The aim...

Download PDF file
  • EP ID EP214678
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

S. M. Tkach, L. A. Onishchuk (2015). Proton Pump Inhibitors and Risk of Drug Interactions. Гастроентерологія, 2(56), 93-98. https://europub.co.uk./articles/-A-214678